Shalby Ltd. · NSE:SHALBY
Shalby — Q4 FY2023 Earnings Presentation
40 slides from Shalby's earnings presentation, May 18, 2023
Slide 1: Exchange filing cover letter
May 18, 2023 Shalby/SE/2023‐24/19 The Listing Department Corporate Service Department National Stock Exchange of India Ltd BSE Limited Mumbai 400 051. Mumbai 400 001. Scrip Code : SHALBY Scrip Code: 540797 Through : https://neaps.nseindia.com/NEWLISTINGCORP/ Through : http://listing.bseindia.com Sub
Slide 2: Investor Presentation Q4 & FY2023
Investor Presentation Q4 & FY2023
Slide 3: Agenda
AGENDA 01 SHALBY GROUP QUARTERLY AND ANNUAL PERFORMANCE 02 HOSPITAL BUSINESS QUARTERLY AND ANNUAL PERFORMANCE 03 HOMECARE BUSINESS QUARTERLY AND ANNUAL PERFORMANCE 04 FRANCHISE BUSINESS QUARTERLY AND ANNUAL PERFORMANCE 05 SHALBY ACADEMY QUARTERLY AND ANNUAL PERFORMANCE 06 IMPLANT BUSINESS QUARTERLY
Slide 4: Q4 FY23 Snapshot
Q4 FY23 Snapshot Consolidated Revenue at Rs 2,082 mn in Q4 FY23 v/s Rs.1,668 mn in Q4 FY22, growth of 25% YoY Financial Highlights Hospital business Revenue at Rs.1,836 mn in Q4 FY23 grew by 21 % YoY from Rs.1,523 mn in Q4 FY22 Implant business Revenue at Rs.208 mn in Q4 FY23 grew by 103% YoY from R
Slide 5: Consolidated Performance Highlights
Consolidated Performance Highlights All figures in INR Million 4th Quarter FY23 Full Year 2023 Revenue EBITDA Revenue EBITDA 2,082 25 % 23 % 8,274 16 % 20 % growth 348 growth growth 1,593 growth 1,668 283 7,114 1,324 19 % 19 % 17 % 17 % FY 22 FY 23 FY 22 FY 23 Q4 FY22 Q4 FY23 Q4 FY22 Q4 FY23 PBT PAT
Slide 6: Consolidated Profit & Loss
Consolidated Profit & Loss All figures in Rs. Million Profit & Loss Balance Sheet Gross 1,417 Q4 Q4 Y-o-Y FY FY Y-o-Y Particulars (Rs. Millions) Borrowings FY23 FY22 Growth 2023 2022 Growth Cash & Cash 2,129 Revenue 2,082 1,668 24.8% 8,274 7,114 16.3% Equivalents1 EBITDA 348 283 23.2% 1,593 1,324 20
Slide 7: Diversification in Revenue Mix
High Growth Business Verticals Healthcare Conglomerate Building An Integrated Orthopedic Solutions Ecosystem Multi-Specialty Single-Specialty Implant 10 Hospitals across western and 4 Shalby Orthopedics Centre of USA based Knee & Hip central India Excellence Manufacturing facility Synergistic Sustai
Slide 8: A Legend and Visionary Doctorpreneur behind Shalby
A Legend and Visionary Doctorpreneur behind Shalby Dr Vikram I. Shah, the Founder of Shalby Ltd, is a world-renowned Joint Replacement Surgeon who innovated “Zero Technique” that revolutionized Joint Replacement Surgery. A visionary entrepreneur, he transformed Shalby from a 6 bedded hospital in 199
Slide 9: Hospital Business Performance
HOSPITAL BUSINESS Performance 8
Slide 10: Hospital Business Highlights Q4 FY23
Hospital Business Highlights Q4 FY23 Global Leader in Arthroplasty with increasing focus on Multi Specialty Surgery Count and YoY Growth Operational Performance Q4 Q4 YoY YoY Particulars FY23 FY22 Nephro & Urology FY23 FY22 Growth Growth Arthroplasty 3,170+ 25% 490+ 22% In-Patient1 (Nos.) 18,551 14.
Slide 11: Hospital Business Highlights Q4 FY23
Hospital Business Highlights Q4 FY23 Financial Performance All Figures are in INR million Revenue EBITDA Profile 1,836 21% 365 13 % YoY YoY 1,523 323 International revenue- Rs.34 mn in Q4 FY23 v/s Rs.16.4 mn in Q4 FY22 21 % 20. % Q4 FY22 Q4 FY23 Q4 FY22 Q4 FY23 Profit Before Tax1 Profit After Tax 17
Slide 12: Specialty Revenue Mix
Hospital Business Highlights Q4 FY23 Specialty Revenue Mix Q4 FY2022 Q4 FY2023 Others, 13% Others, 13% Nephrology, Arthroplasty, 5% Arthroplasty, Nephrology, 37% 41% 4% Neurology, Neurology, 6% 4% Orthopaedic, Orthopaedic, 7% 9% Oncology, 10% Oncology, 10% Critical Care & General Critical Care & Gen
Slide 13: Payor Mix
Hospital Business Highlights Q4 FY23 Payor Mix Q4 FY2022 Q4 FY2023 Corporate, Corporate, 3% 1% Self Pay, 37% Self Pay, 36% Government, 25% Government, 23% Insurance, Insurance, 37% 40% 12
Slide 14: Homecare Business Highlights Q4 and FY 2023
Homecare Business Highlights Q4 and FY 2023 Q4 FY2023 Highlights Patients Served (Nos) 27,001 34 % Patients Served 7,139 in Q4 FY23 v/s 5,198 patients in Q4 FY22, YoY grew by 37% YoY 20,097 Revenue booked Rs.28 mn in Q4 FY23 v/s Rs.19 mn in Q4 FY22, grew by 47% YoY FY22 FY23 Achieved more than 425 T
Slide 15: Hospital Business Highlights (FY 2023)
Hospital Business Highlights (FY 2023) Shalby Continued to deliver high double-digit growth over the last 2 decades Revenue EBITDA 7,274 1,615 6,598 1,426 778 3,284 439 1,685 194 22 FY 2007 FY 2012 FY 2017 FY 2022 FY 2023 FY 2007 FY 2012 FY 2017 FY 2022 FY 2023 Note: Above all numbers are on Standal
Slide 16: Surgery Count and YoY Growth
Hospital Business Highlights (FY 2023) Surgery Count and YoY Growth 13,180+ 43% 870+ 43% Arthroplasty Cardiac Surgeries in other specialties 2,045+ 56% 2,070+ 41% have grown by high General & Cosmetic double digit Nephro & Urology 1,470+ 48% 3,360+ 31% Oncology Orthopedic 15
Slide 17: Hospital Business P&L and B/S
Hospital Business P&L and B/S Profit & Loss (Rs. Mn) Total Revenue to EBITDA Q4 Q4 YoY YoY FY23 FY22 Particulars (Rs Millions) FY23 FY22 Growth Growth Consistent Double Digit Total Revenue 1,836 1,523 21% 7,274 6,598 10% 21.2% Operating 19.9% EBITDA Margin EBITDA 365 323 13% 1,615 1,426 13% Material
Slide 18: 3 Year Annual Performance Trends
3 Year Annual Performance Trends In-Patient Count Surgery Count 27,352 71,893 61,173 20,240 48,515 11,933 FY 21 FY 22 FY 23 FY 21 FY 22 FY 23 Occupied Bed ARPOB1 (Rs) 563 570 34,842 31,347 428 27,400 FY 21 FY 22 FY 23 FY 21 FY 22 FY 23 Total Revenue (Rs. Mn) EBITDA (Rs. Mn) 7,274 6,598 1,615 1,426 4
Slide 19: Clinical Update And Research Across Units during Q4 FY23
Clinical Update And Research Across Units during Q4 FY23 ▪ Till date we have performed 220+ Transplants (Kidney and Liver) at Shalby SG and Indore hospital units ▪ First case of TAVI (Trans catheter Aortic Valve Implantation) performed successfully in Shalby Hospital Jaipur ▪ Implanted a novel devic
Slide 20: Key Focus Areas For Future In Hospital business
Key Focus Areas For Future In Hospital business Global Leader in Joint Replacement with diversification in other specialties • Continue to maintain global leadership in joint replacements • Ongoing diversification with Cardiac Science, Oncology, Neuro-science, Critical Care, General Medicine and Tra
Slide 21: Hospital Journey & Further Expansion
Hospital Journey & Further Expansion Expansion in Pipeline Mumbai Bed Capacity: 175 Jaipur Shalby, Jaipur (237 beds) Business Model: Revenue Sharing O&M Period: 30 + 30 years Naroda Shalby, Ahmedabad (267 beds) Operationalization Year: 2025-26 Vapi Shalby, Vapi (146 beds) Estimated Cost: Rs. 1,600 m
Slide 22: SOCE Franchise Performance
SOCE Franchise Performance 21
Slide 23: Leveraging Expertise Through Franchise Asset Light Model Under SOCE
Leveraging Expertise Through Franchise Asset Light Model Under SOCE SHALBY ORTHOPEDIC CENTRE OF EXCELLENCE An Asset light franchise model will leverage Shalby expertise and enable to penetrate faster across pan-India Business models SOCE Performance Bed Capacity FY 2023 Franchise Owned – Shalby Oper
Slide 24: Shalby Academy
CO) SHALBY ACADEMY oo SHALBY ACADEMY oi
Slide 25: Shalby Academy (Providing Industry Ready Education)
Shalby Academy (Providing Industry Ready Education) Q4 FY23 highlights Students Enrolled (In Nos) 1. 240+ students have registered for Paramedical Courses at Various Locations for the Academic Year (22-23). 2,062 17x growth 2. Provided internship to more than 500 physiotherapist 1,454 1,129 1,142 3.
Slide 26: Implant Business Performance
IMPLANT BUSINESS Performance 25
Slide 27: Diversified into Knee and Hip Implant Manufacturing In California, USA
Diversified into Knee and Hip Implant Manufacturing In California, USA Backward integration in Orthopedics with Inhouse capacity to consume in India 80,000+ Vertically integrated In- Components High Quality US FDA house manufacturing Manufacturing Approved Implants Facility capacity Surgeon’s Traini
Slide 28: Implant Business Performance FY 2023
Implant Business Performance FY 2023 Total Constructs EBITDA Revenue Sold Rs. 939 mn Rs. 11 mn 9700+ Geographical Sales Mix USA Customer Sales Mix Product Sales Mix Wholes India, ale, 41% Knee, USA, 42% 63% 59% FY 2023 FY 2023 FY 2023 Hip, Retail, 37% 58% 27
Slide 29: Implant Business Roadmap
Implant Business Roadmap Shalby Advanced Technologies plans to become a Global player in a phased manner Existing Phase 1 Phase 2 Phase 3 Market Latin America Middle East Countries East Africa North America • Argentina • UAE • Kenya • Columbia • Saudi Arabia • Ethiopia Japan South East and North • O
Slide 30: 29 Years of ELITE Legacy
29 Years of ELITE Legacy Integrity Highest standards of transparency accountability, and corporate governance Learning Team Work Lazer sharp focus on A patient-centric focused upgrading the skills of team with a great blend of our team and building experience, diversity, fresh people capability thin
Slide 31: Hospitals Portfolio
Hospitals Portfolio Multispecialty Units (Owned and Managed) SOCE Vijay Shalby Vapi Shalby Indore Shalby Jaipur Shalby Udaipur Shalby Krishna Shalby Mohali Shalby Naroda Shalby Lucknow Shalby SG Shalby Jabalpur Shalby Zynova Shalby Surat Shalby Gwalior Shalby (Mumbai) 30 SOCE- Shalby Orthopedics Cen
Slide 32: Biggest Healthcare Corporate Group in Western and Central India
Biggest Healthcare Corporate Group in Western and Central India National Presence 10 Multispecialty and 4 Single specialty Hospital (SOCE) 2000+ Bed Capacity in 11 cities 59 OPDs across 16 states PUNJAB ▪ Mohali – 145 beds Uttar Pradesh ▪ Lucknow – 40 beds Upcoming 2 Units (321 Beds) RAJASTHAN ▪ Jai
Slide 33: Healthcare Awareness Programs
Sustainability Initiatives in FY2023 ESG Mindset “We at Shalby are embracing sustainability to drive new values to our business” Community Connect Trainings 38,800+ and 24,200+ Man Hours 935+ Healthcare Camps Healthcare Awareness Programs Clinical and Non-Clinical training provided Workplace Wellnes
Slide 34: Workplace Wellness
Sustainability Initiatives in FY2023 ESG Mindset Shalby Life Saviour program to outside community as a part of healthcare awareness Community Connect Educational Institutions Trained 937 Students & Teachers Total Training Hours invested 1,405 Workplace Wellness Corporate Institutions Trained 2239 Co
Slide 35: Experienced Board Of Directors
Experienced Board Of Directors Dr. Vikram Shah Mr. Sushobhan Dasgupta Dr. Ashok Bhatia Chairman and Managing Director Non – Executive Director Non- Executive Director A strategist with 30+ years of experience in the field of Almost three decades of professional healthcare healthcare, worked in sever
Slide 36: Shalby In News
Shalby In News Shalby featured in Medgate Today Interview with Moneycontrol Interview of Shanay Shah, President on Dalal Street An Article by Dr Vikram Shah, CMD on Medical Buyer CNBC TV 18 interviewing Mr Shanay Shah, President on Shalby’s business outlook 35
Slide 37: Shalby In News
Shalby In News 165 KG Patent Knee Replacement Surgery Organ Donation at Shalby SG Shalby Partnering Multi Organ Centre of Western India with Google… in association with Global Hospital. Partial Knee Replacement in Shalby, Surat Nerve block technique during Joint Replacement surgery in Shalby Jaipur
Slide 38: Shalby In News
Shalby In News Shalby Surat completed 5 years World Alzheimer Day Industry Stories & Doctors World Heart Day Quotes Participated as a Medical Healthcare Camps Support Team in 36th National games, Gujarat 2022 for wrestling and Boxing Emergency training camp in Mumbai Best Organ Transplant Coordinato
Slide 39: Shalby - Awards & Recognition in FY 2023
Shalby- Awards & Recognition in FY 2023 The Economic Times Healthcare Awards Shalby Jaipur is AHPI Patient Esteemed award to Lifeline award to 2022 for Awarded for awarded for Centric Hospital by Shalby Indore at Shalby Indore the Best Orthopedic “Excellence in Knee AHPI (Association Health Conclave
Slide 40: Disclaimer and Contact Details
DISCLAIMER and CONTACT DETAILS No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as